万古霉素诱导的血小板减少症:叙述性综述
该反应似呈时间依赖性,病例中血小板最低值平均出现在用药后8天,再暴露时间隔可能显著缩短;出血患者血小板最低值为2000-100000/mL。
要点
- 万古霉素诱导血小板减少症呈时间依赖性,病例中血小板最低值平均见于用药后8天。
- 再暴露时血小板下降间隔可能显著缩短,需警惕再次用药风险。
- 严重血小板减少伴出血时可考虑输血,难治性病例可保留使用IVIG、糖皮质激素等。
核心结论
- 万古霉素可诱导血小板减少症,该反应似呈时间依赖性,再暴露时间隔可能显著缩短。
研究设计与样本
- 叙述性综述,检索PubMed、Scopus和Web of Science数据库,纳入2015年7月前发表的英文文献。
主要发现
- 主要给药途径为静脉输注。
- 报告病例中血小板最低值平均出现在用药后8天,再暴露时间隔可能显著缩短。
- 发生出血的患者血小板最低值范围为2000-100000/mL。
- 病例报告中17例接受检测的患者中13例检出万古霉素特异性抗体。
- Naranjo不良反应概率量表评估:1例为「肯定」、15例为「很可能」、14例为「可能」。
关键数值与推荐
- 30例中29例停用万古霉素,其中17例血小板在5-6天内恢复正常。
- 1例未停用万古霉素,血小板在最低值后11天恢复。
- 严重血小板减少伴出血时可推荐输血。
- 难治性血小板减少伴严重出血可保留使用静脉免疫球蛋白、糖皮质激素、利妥昔单抗和血浆置换。
临床怎么用
- 使用万古霉素期间应监测血小板计数,尤其再暴露和长期用药患者。
- 怀疑万古霉素诱导血小板减少时应评估停药指征,多数病例停药后血小板可恢复。
- 严重血小板减少伴出血时可考虑输血,难治性病例可保留免疫调节治疗。
局限性
- 纳入文献以病例报告为主,缺乏大规模前瞻性研究数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombocytopenia has been reported as an adverse reaction of numerous drugs. Vancomycin is often overlooked as a culprit but has been associated with several cases of thrombocytopenia that were not well described in the literature. A literature search was conducted to find reports of thrombocytopenia induced by vancomycin. Biomedical databases including 'PubMed', 'Scopus', and 'Web of Science' were searched using terms 'vancomycin', 'platelet', 'pancytopenia', 'thrombocytopenia', and 'bleeding'. English language articles published before July 2015 were included. Thirty-nine papers including 29 case reports (30 cases), five observational studies, two clinical trials, two letters, and one case series remained for final analysis. The main route of administration was intravenous infusion. This adverse reaction seems to be duration dependent with the mean time to platelet nadir count of 8 days in reported cases. The interval may be significantly shorter in re-exposure to the drug. Platelet nadir counts ranged from 2000 to 100,000/mL in patients who experienced bleeding. Vancomycin-specific antibodies were detected in 13 of 17 patients who were tested in the case reports. Based on the Naranjo Adverse Drug Reaction Probability Scale, reaction was 'definite', 'probable', and 'possible' in 1, 15, and 14 patients, respectively. Among 30 cases, vancomycin was discontinued in 29 patients and platelets returned to normal counts within 5-6 days in 17 of them; in one patient, vancomycin was not discontinued, but platelet count recovered 11 days after the nadir time. Transfusion might be recommended if severe thrombocytopenia and bleeding occurs. Intravenous immunoglobulins, corticosteroids, rituximab, and plasma exchange should be reserved for patients with resistant thrombocytopenia and severe bleeding as mentioned in a number of reports.
引用
- Mohammadi M, Jahangard-Rafsanjani Z, Sarayani A, et al. Vancomycin-Induced Thrombocytopenia: A Narrative Review. Drug Saf. 2017. PMID: 27848200. doi:10.1007/s40264-016-0469-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。